M. Neidhart et al., THE LEVELS OF MEMORY (CD45RA-, RO-BLOOD T-LYMPHOCYTES CORRELATE WITH IGM RHEUMATOID FACTORS IN RHEUMATOID-ARTHRITIS() CD4+ AND CD8+ PERIPHERAL), Rheumatology international, 15(5), 1996, pp. 201-209
We investigated whether, in rheumatoid arthritis (RA), the CD45 isofor
m expression of peripheral blood T-lymphocytes (T-PBL) is related to a
uto-immune processes (e.g. IgM rheumatoid factors) and to clinical man
ifestations. By three-colour flow cytometry, we quantified three subse
ts of CD4+ or CD8+ T-PBL: ''naive'' CD45RA+,RO-, ''transient'' CD45RA,RO+, and ''memory'' CD45RA-,RO+ cells, in 102 patients with RA and in
41 age- and sex-matched controls. The serum levels of rheumatoid fact
ors (RF) were determined - besides conventional agglutination tests -
by ELISA (IgM-RF). Extensive clinical examination was performed at the
time of blood sampling. In RA, age, sex and drug therapy did not cons
titute major influences on the CD45R/RO patterns. In ''healthy'' men,
higher age significantly correlated with fewer naive and more memory C
D4+ T-PBL (P<0.01). In RA, distinct correlations between the T-PBL sub
sets, autoimmune and clinical manifestations became obvious when patie
nts with low and high levels of RF against human IgG Fc fragments, as
determined by ELISA, were analysed separately. RA patients with high I
gM-RF had elevated proportions of CD45RO+ T-PBL (P<0.05), that correla
ted with clinical parameters of disease activity (tender joint count,
Ritchie index, P<0.05) and outcome (Health Assessment Questionnaire, L
arsen radiographic scores, P<0.05). The proportions of memory CD4+ and
CD8+ T-PBL correlated strongly (P<0.001) with the IgM-RF levels. With
in 1 year, only three of 34 patients (disease duration of 5-9 years) s
howed seroconversion from low to high levels of IgM-RF (and positive a
gglutination tests); this was paralleled by reductions in naive and in
creases in transient T-PBL (P<0.02). Thus, in RA, the proportions of m
emory CD4+ and CD8+ T-PBL correlate with the level of IgM-RF and, toge
ther with transient T-PBL, with clinical parameters of disease activit
y and outcome.